Results 171 to 180 of about 362,523 (334)

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source

Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort

Interdisciplinary Medicine, EarlyView.
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li, Shun Wang, Guowei Zhao, Jiangtao Li, Xin Li, Bingning Wang, Yi Zhang, Mengfei Yao, Lei Guo, Jianming Ying, Wenbin Li   +10 more
wiley   +1 more source

Evaluation of the efficacy as well as prognosis of targeted therapy for advanced non-small cell lung cancer patients with different expression of miR-183 family in body fluids. [PDF]

Front Med (Lausanne)
Chen M, Shen Y.
europepmc   +1 more source

C2-05: Is mediastinoscopy necessary for T1N0 NSCLC on both CT and integrated PET/CT scan? [PDF]

, 2007
Yong Soo Choi, Kwhanmien Kim, Young Tae Kim, Byung‐Tae Kim, Kyung Soo Lee, Young Mog Shim   +5 more
openalex   +1 more source

Molecular crosstalk via exosomes in lung cancer progression

Interdisciplinary Medicine, EarlyView.
“Molecular and theranostics roles of exosomes in Lung Cancer.” Abstract Exosomes play a critical role in lung cancer metastasis, facilitating tumor progression through intercellular communication between cancer cells and the tumor microenvironment. These nanosized extracellular vesicles carry bioactive molecules such as proteins, nucleic acids, and ...
Rajib Dhar, Vinoth Kumarasamy, Brian G. Oliver, Vetriselvan Subramaniyan   +3 more
wiley   +1 more source

CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A. [PDF]

J Cancer
Luo P, Huang Z, Ding S, Tang Z, Wei Y, Jiang S, Tang R, Li F, Yang H, Zhao L.   +9 more
europepmc   +1 more source

Integrating Clinical Features, Laboratory Biomarkers and Computed Tomography for the Discrimination of Non‐Small Cell Lung Cancer and Benign Pulmonary Diseases: A Clinical Prediction Model

Journal of Clinical Laboratory Analysis, EarlyView.
This study developed and validated a clinical prediction model to differentiate non‐small cell lung cancer (NSCLC) from benign pulmonary diseases using clinical features, laboratory biomarkers, and CT features. The model achieved an AUC‐ROC of 0.95 in the training set and 0.82 in the validation set, demonstrating reliable diagnostic performance and ...
Jie Zhang, Shui Liu, Mingjian Bai, Fucun Ma, Guowei Liang, Bing Wang   +5 more
wiley   +1 more source

Optimal Treatment Strategies for Pulmonary Large Cell Neuroendocrine Carcinoma Based on Molecular Subtypes. [PDF]

J Clin Med
Yücel H, Kuş T, Cangi S, Aktaş G.
europepmc   +1 more source

Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients

Se‐Hoon Lee, Sujeong Kim, Jueun Lee, Yun-Jae Kim, Young Hoon Joo, Jun-Yeong Heo, Heeyeon Lee, Charles Lee, Geum‐Sook Hwang, Hansoo Park   +9 more
openalex   +2 more sources

EP-1725: Predicting radiation-induced pneumonitis in NSCLC: a radiobiological and texture analysis study

, 2017
William H. Nailon, Wei Lü, Dean Montgomery, L. Carruthers, J. Murchiston, An Yong, G. W. Ritchie, T. Evans, F. Little, Simon Erridge, A. Price, Duncan B. McLaren, S. Campbell   +12 more
openalex   +1 more source